Showing results (1-10 of 58) with videos related to
Sort By:
Pageof 6
Frontiers in Immunology|July 15, 2022
Dendritic Cells and Macrophages in the Pathogenesis of PsoriasisMasahiro Kamata, Yayoi TadaInternational Journal of Molecular Sciences|March 4, 2020
Efficacy and Safety of Biologics for Psoriasis and Psoriatic Arthritis and Their Impact on Comorbidities: A Literature ReviewMasahiro Kamata, Yayoi TadaJID Innovations : Skin Science From Molecules to Population Health|December 15, 2021
A Literature Review of Real-World Effectiveness and Safety of Dupilumab for Atopic DermatitisMasahiro Kamata, Yayoi TadaJID Innovations : Skin Science From Molecules to Population Health|May 14, 2023
Optimal Use of Jak Inhibitors and Biologics for Atopic Dermatitis on the Basis of the Current EvidenceMasahiro Kamata, Yayoi TadaFrontiers in Immunology|November 29, 2023
Crosstalk: keratinocytes and immune cells in psoriasisMasahiro Kamata, Yayoi TadaThe Journal of Dermatology|December 12, 2017
Safety of biologics in psoriasisMasahiro Kamata, Yayoi TadaThe Journal of Dermatological Treatment|September 8, 2025
Duration of current alopecia areata episode predicts the effectiveness of baricitinib in Japanese patients with alopecia areata: a single-center retrospective studyMariko Niki, Masahiro Kamata, Yayoi Tada, et al.The Journal of Allergy and Clinical Immunology. in Practice|May 14, 2025
Deciding Which Patients With Atopic Dermatitis to Prioritize for Biologics and Janus Kinase InhibitorsMasahiro Kamata, Dingyuan I Sun, Amy S PallerHuman Immunology|September 21, 2010
Increased serum leucine, leucine-37 levels in psoriasis: positive and negative feedback loops of leucine, leucine-37 and pro- or anti-inflammatory cytokinesNaoko Kanda, Takeko Ishikawa, Masahiro Kamata, et al.Journal of Leukocyte Biology|March 4, 2011
Human β-defensin-2 enhances IFN-γ and IL-10 production and suppresses IL-17 production in T cellsNaoko Kanda, Masahiro Kamata, Yayoi Tada, et al.Pageof 6